checkAd

     241  0 Kommentare G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit

    RESEARCH TRIANGLE PARK, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Medical Officer Dr. Raj Malik and Chief Commercial Officer Andrew Perry will participate in a fireside chat at TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA, on Wednesday, May 29, at 8:30AM EDT.

    The webcast of the event will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

    About G1 Therapeutics
    G1 Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical company whose mission is to develop and deliver next-generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA (trilaciclib). The Company is also evaluating therapies in combination with cytotoxic therapies and/or immunotherapy in areas of high unmet need including triple-negative breast cancer and extensive stage small cell lung cancer. G1’s goal is to provide innovative therapeutic advances for people living with cancer. G1 is based in Research Triangle Park, N.C. For additional information, please visit http://www.g1therapeutics.com and follow us on X (formerly known as Twitter) @G1Therapeutics and LinkedIn.

    G1 Therapeutics and the G1 Therapeutics logo and COSELA and the COSELA logo are trademarks of G1 Therapeutics, Inc.

    Lesen Sie auch

    Contacts:
    Will Roberts
    Communications Officer
    Vice President, Investor Relations and Corporate Communications
    (919) 907-1944
    wroberts@g1therapeutics.com





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit RESEARCH TRIANGLE PARK, N.C., May 22, 2024 (GLOBE NEWSWIRE) - G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Medical Officer Dr. Raj Malik and Chief Commercial Officer Andrew Perry will …

    Schreibe Deinen Kommentar

    Disclaimer